Isolation, characterization, and expression of feline stromelysin-1 in naturally developing tumors in cats

American Journal of Veterinary Research

Volumn 65, Issue 2, 2004, Pages 213-219

  Sorensen, Kara C ^a   Kitchell, Barbara E ^a,b   Siegel, Arthur M ^a   Mardis, Paul ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MATRIX METALLOPROTEINASE; RNA; STROMELYSIN; PRIMER DNA;

AGE DISTRIBUTION; AMINO ACID SEQUENCE; ARTICLE; CANCER GROWTH; CAT DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE COURSE; FIBROSARCOMA; GENE AMPLIFICATION; GENE IDENTIFICATION; METASTASIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN ISOLATION; SCREENING TEST; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SEX DIFFERENCE; SPECIES DIFFERENCE; SURVIVAL TIME; TUMOR BIOPSY; TUMOR DIAGNOSIS; ANIMAL; ANIMAL DISEASE; CAT; COMPARATIVE STUDY; DNA SEQUENCE; GENE EXPRESSION; GENETICS; MOLECULAR GENETICS; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

FELIDAE; FELIS CATUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CAT DISEASES; CATS; DNA PRIMERS; GENE EXPRESSION; MATRIX METALLOPROTEINASE 3; MOLECULAR SEQUENCE DATA; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 1542300782     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.213     Document Type: Article

References (53)

1. Vaes G. The release of collagenase as an inactive proenzyme by bone explants in culture. Biochem J 1972;126:275-289.
2. Chin JR, Murphy G, Werb Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem 1985;260:12367-12376.
3. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 1986; 261:14245-14255.
4. Sellers A, Reynolds JJ, Meikle MC. Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans. Biochem J 1978;171:493-496.
5. Durke M, Brodt P. The metalloproteinases and their inhibitors. In: Brodt P, ed. Cell adhesion and invasion in cancer metastasis. Austin, Texas: Chapman & Hall, 1996;113-150.
6. Galloway WA, Murphy G, Sandy JD, et al. Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J 1983; 209:741-752.
7. Vater CA, Nagase H, Harris ED Jr. Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. J Biol Chem 1983;258:9374-9382.
8. Wilhelm SM, Eisen AZ, Teter M, et al. Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Natl Acad Sci U S A 1986;83:3756-3760.
9. Whitham SE, Murphy G, Angel P, et al. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J 1986;240:913-916.
10. Matrisian LM, Bowden GT, Krieg P, et al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A 1986;83: 9413-9417.
11. Matrisian LM, Leroy P, Ruhlmann C, et al. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol 1986;6:1679-1686.
12. Murphy G, Cawston TE, Galloway WA, et al. Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J 1981;199:807-811.
13. Pelletier JP, Martel-Pelletier J, Ghandur-Mnaymneh L, et al. Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1985; 28:554-561.
14. Murphy G, Cockett MI, Stephens PE, et al. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 1987;248:265-268.
15. Kouwenhoven M, Ozenci V, Tjernlund A, et al. Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis. J Neuroimmunol 2002;126:161-171.
16. Wilhelm SM, Collier IE, Kronberger A, et al. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A 1987;84:6725-6729.
17. Matrisian LM, McDonnell S, Miller DB, et al. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991;302:157-162.
18. McDonnell SE, Kerr LD, Matrisian LM. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 1990;10:4284-4293.
19. Nelimarkka LO, Nikkari ST, Ravanti LS, et al. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro. Matrix Biol 1998;17:293-304.
20. Tomita T, Nakase T, Kaneko M, et al. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase in rheumatoid arthritis. Arthritis Rheum 2002;46:373-378.
21. Cawston TE, Galloway WA, Mercer E, et al. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981;195:159-165.
22. D'Souza CA, Mak B, Moscarello MA. The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease. J Biol Chem 2002;277:13589-13596.
23. Bannikov GA, Karelina TV, Collier IE, et al. Substrate binding of gelatinase B induced its enzymatic activity in the presence of intact propeptide. J Biol Chem 2002;277:16022-16027.
24. Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 1988;267:211-216.
25. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992;267:3581-2584.
26. De Angelis T, Noe A, Chaterjee M, et al. Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma. J Invest Dermatol 2002;118:759-766.
27. Ferrans VJ. New insights into the world of matrix metalloproteinases. Circulation 2002;105:405-407.
28. Arai Y, Kubo T, Kobayashi K, et al. Adenovirus vector-mediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction. J Rheumatol 1997;124:1787-1795.
29. Madlener M, Parks WC, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998;242:201-210.
30. Balkman CE, Nixon AJ. Molecular cloning and cartilage gene expression of equine stromelysin 1 (matrix metalloproteinase 3). Am J Vet Res 1998;59:30-36.
31. Giambernardi TA, Grant GM, Taylor GP, et al. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 1998;16:483-496.
32. Close DR. Matrix metalloproteinase inhibitors in rheumatic diseases. Ann Rheum Dis 2001;60(suppl 3):iii62-iii67.
33. Panula HE, Lohmander LS, Ronkko S, et al. Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial vaigus osteotomy in young beagle dogs. Acta Orthop Scand 1998;69:152-158.
34. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/ stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-146.
35. Matrisian L. Cancer biology: extracellular proteinases in malignancy. Current Biol 1999;9:R776-R778.
36. Giroldi L, Hollstein M, Yamasaki H. Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects. Carcinogenesis 1988;9:817-821.
37. Nikkola J, Vihinen P, Vlaykova T, et al. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 2002;97:432-438.
38. Carrell TWG, Burnand KG, Wells GMA, et al. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are over expressed in the wall of abdominal aortic aneurysms. Circulation 2001;105:477-482.
39. Wolfe GC, MacNaul KL, Buechel FF, et al. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 1993;36:1540-1547.
40. Zucker S, Lysik RM, Zarrabi MH, et al. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140-146.
41. Templeton NS, Stetler-Stevenson WG. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res 1991; 51:6190-6193.
42. Chirgwin JM, Przybyla AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
43. Houts G, Miyagi M, Ellis C, et al. Reverse transcriptase from avian myeloblastosis virus. J Virol 1979;29:517-522.
44. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
45. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
46. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958;53:457-481.
47. Springman EB, Angleton EL, Birkedal-Hansen H, et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A 1990;87:364-368.
48. Wetmore DR, Hardman KD. Roles of the propeptide and metal ions in the folding and stability of the catalytic domain of stromelysin (matrix metalloproteinase 3). Biochemistry 1996; 35:6549-6558.
49. Murphy GJ, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 1991; 289:4-7.
50. Sang QA, Douglas DA. Computational sequence analysis of matrix metalloproteinases. J Protein Chem 1996;15:137-160.
51. Ghilardi G, Biondi ML, Caputo M, et al. A single nucleotide polymorphism in matrix metalloproteinase 3 promoter enhances breast cancer susceptibility. Clin Cancer Res 2002; 8:3820-3823.
52. Hinoda Y, Okayama N, Takano N, et al. Associations of functional polymorphisms of matrix metalloproteinase (MMP)-1 and -3 genes with colorectal cancer. Int J Cancer 2002;102:526-529.
53. Pollanen PJ, Lehtimaki T, Ilveskoski E, et al. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki sudden death study. Atherosclerosis 2002; 164:329-335.